Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lesley Jones

Showing results (111-120 of 138) with videos related to

Pageof 14
Sort By:
Human Molecular Genetics|December 8, 2007
Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's diseaseYonghong Li, Andrew Grupe, Charles Rowland, et al.
Human Molecular Genetics|February 10, 2006
Regional and cellular gene expression changes in human Huntington's disease brainAngela Hodges, Andrew D Strand, Aaron K Aragaki, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 25, 2005
Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's diseasePeter Holmans, Marian Hamshere, Paul Hollingworth, et al.
Brain : a Journal of Neurology|October 23, 2015
Common polygenic variation enhances risk prediction for Alzheimer's diseaseValentina Escott-Price, Rebecca Sims, Christian Bannister, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 13, 2019
Tackling gaps in developing life-changing treatments for dementiaRui Mauricio, Caroline Benn, John Davis, et al.
American Journal of Medical Genetics|February 22, 2002
Full genome screen for Alzheimer disease: stage II analysisAmanda Myers, Fabienne Wavrant De-Vrieze, Peter Holmans, et al.
Human Molecular Genetics|May 24, 2007
Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosageAlexandre Kuhn, Darlene R Goldstein, Angela Hodges, et al.
American Journal of Human Genetics|March 24, 2022
Genetic modifiers of Huntington disease differentially influence motor and cognitive domainsJong-Min Lee, Yuan Huang, Michael Orth, et al.
Human Molecular Genetics|December 11, 2012
A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's diseasePeter Holmans, Valentina Moskvina, Lesley Jones, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2025
APMAT analysis reveals the association between CD8 T cell receptors, cognate antigen, and T cell phenotype and persistenceJingyi Xie, Daniel G Chen, William Chour, et al.
Pageof 14

Showing results (111-120 of 138) with videos related to

Sort By:
Pageof 14
Human Molecular Genetics|December 8, 2007
Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's diseaseYonghong Li, Andrew Grupe, Charles Rowland, et al.
Human Molecular Genetics|February 10, 2006
Regional and cellular gene expression changes in human Huntington's disease brainAngela Hodges, Andrew D Strand, Aaron K Aragaki, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 25, 2005
Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's diseasePeter Holmans, Marian Hamshere, Paul Hollingworth, et al.
Brain : a Journal of Neurology|October 23, 2015
Common polygenic variation enhances risk prediction for Alzheimer's diseaseValentina Escott-Price, Rebecca Sims, Christian Bannister, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 13, 2019
Tackling gaps in developing life-changing treatments for dementiaRui Mauricio, Caroline Benn, John Davis, et al.
American Journal of Medical Genetics|February 22, 2002
Full genome screen for Alzheimer disease: stage II analysisAmanda Myers, Fabienne Wavrant De-Vrieze, Peter Holmans, et al.
Human Molecular Genetics|May 24, 2007
Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosageAlexandre Kuhn, Darlene R Goldstein, Angela Hodges, et al.
American Journal of Human Genetics|March 24, 2022
Genetic modifiers of Huntington disease differentially influence motor and cognitive domainsJong-Min Lee, Yuan Huang, Michael Orth, et al.
Human Molecular Genetics|December 11, 2012
A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's diseasePeter Holmans, Valentina Moskvina, Lesley Jones, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2025
APMAT analysis reveals the association between CD8 T cell receptors, cognate antigen, and T cell phenotype and persistenceJingyi Xie, Daniel G Chen, William Chour, et al.
Pageof 14